Letter: ACE2, IBD and COVID-19-why IBD patients may be at reduced risk of COVID-19.
Ralley E PrenticeDouglas TjandraMayur GargJohn S LubelSpiros FourlanosDoug JohnsonAysha Al-AniBritt ChristensenPublished in: Alimentary pharmacology & therapeutics (2020)